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Abstract
In our previous study, complete protection was observed in Chinese-origin rhesus macaques immunized with SV1 (20 mgF 1
and 10 mg rV270) and SV2 (200 mg F1 and 100 mg rV270) subunit vaccines and with EV76 live attenuated vaccine against
subcutaneous challenge with 6610
6 CFU of Y. pestis. In the present study, we investigated whether the vaccines can
effectively protect immunized animals from any pathologic changes using histological and immunohistochemical
techniques. In addition, the glomerular basement membranes (GBMs) of the immunized animals and control animals were
checked by electron microscopy. The results show no signs of histopathological lesions in the lungs, livers, kidneys, lymph
nodes, spleens and hearts of the immunized animals at Day 14 after the challenge, whereas pathological alterations were
seen in the corresponding tissues of the control animals. Giemsa staining, ultrastructural examination, and
immunohistochemical staining revealed bacteria in some of the organs of the control animals, whereas no bacterium
was observed among the immunized animals. Ultrastructural observation revealed that no glomerular immune deposits on
the GBM. These observations suggest that the vaccines can effectively protect animals from any pathologic changes and
eliminate Y. pestis from the immunized animals. The control animals died from multi-organ lesions specifically caused by the
Y. pestis infection. We also found that subcutaneous infection of animals with Y. pestis results in bubonic plague, followed by
pneumonic and septicemic plagues. The histopathologic features of plague in rhesus macaques closely resemble those of
rodent and human plagues. Thus, Chinese-origin rhesus macaques serve as useful models in studying Y. pestis pathogenesis,
host response and the efficacy of new medical countermeasures against plague.
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Introduction
Plague is a zoonotic infectious disease caused by the Gram-
negative bacterium Yersinia pestis. Historically, plague is an awful
infectious disease that afflicts human populations, leading to
millions of deaths. Plague has been recently classified as a re-
emerging disease by the World Health Organization [1] and has
attracted considerable attention because of its potential misuse
as an agent of biological warfare or bioterrorism [2]. Most
human plague cases clinically present as one of three primary
forms—bubonic, septicemic and pneumonic. Bubonic plague is
the most common form of the disease, which occurs when Y.
pestis is inoculated into the skin. Primary bubonic or septicemic
plague is usually caused by fleabite among rodent reservoir hosts
and most human cases are usually transmitted from an infected
rodent via the bite of an infected flea, whereas pneumonic
plague usually spread by respiratory droplets. Patients with
primary bubonic plague can develop secondary septic or
pneumonic infection, which can then be spread from person-
to-person via respiratory droplets generated from sneezing and
coughing [3].
To evaluate plague vaccines, several animal models, such as
mice, guinea pigs, rabbits [4] and cynomolgus macaques [5], have
been used to determine protective efficacy against Y. pestis
challenge and antibody responses to plague vaccines. On the
other hand, to assess the animal models of bubonic plague,
pathological characteristics during bubonic infection have been
investigated in mice [6], cats [7] and guinea pigs [3]. Pneumonic
plague is the form most likely to be observed in biological warfare
or bioterrorism events and interest in animal models has been
raised to support plague therapeutic and vaccine studies.
Pathological features of pneumonic plague have been observed
in mice [8,9], rats [10], Indonesian cynomolgus macaques [11]
and African green monkeys [12].
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and survival rate after challenging with Y. pestis [5]. In our previous
study [13], Chinese-origin rhesus macaques were used as an
animal model to evaluate the protective efficacy of subunit
vaccines SV1 (20 mg F1 and 10 mg rV270) and SV2 (200 mg
F1+100 mg rV270), and a live attenuated vaccine EV76 against
subcutaneous challenge with a virulent Y. pestis 141 strain.
Complete protection was observed in the animals immunized
with SV1, SV2, and live attenuated vaccine EV76 against
subcutaneous challenge with 6610
6 colony-forming units (CFU)
of virulent Y. pestis strain 141. The control animals succumbed to
the same dose of Y. pestis 141 within 3 to 5 days [13]. However,
whether F1+rV270 subunit vaccines and EV76 live attenuated
vaccine can effectively protect the immunized animals from any
pathological changes remain unknown.
In the present study, we examined liver, spleen, lung, kidney,
heart and lymph node tissues from Chinese-origin rhesus
macaques immunized with SV1, SV2, and EV76 that were
subcutaneously infected with virulent Y. pestis 141. Additionally,
the control animals were examined by histopathological methods.
The Y. pestis distribution in tissues was determined with Giemsa
staining under light microscopy, transmission electron microscopy,
and immunohistochemistry. In addition, the glomerular immune
deposits in the immunized animals and in the control animals were
checked by electron microscopy.
Results
Tissue injury after infection with Y. pestis
After challenging with virulent Y. pestis 141, the lungs, livers,
kidneys, lymph nodes, spleens, and hearts of the animals
immunized with SV1, SV2, and EV76, and the control animals
immunized with adjuvant were collected, fixed in 10% neutral
buffered formalin, and prepared for HE staining. One normal
macaque that was neither immunized with plague vaccines or
adjuvant nor infected with Y. pestis was used as the naı ¨ve control.
Compared with the lung, lymph node, liver, spleen, kidney, and
heart tissues of the naı ¨ve control animal (Fig. 1 a–f, Panel A), no
changes in histopathology were found in all examined tissues from
the animals immunized with SV1 (Fig. 1 a–f, Panel C), SV2 (Fig. 1
a–f, Panel D), and EV76 (Fig. 1 a–f, Panel E), whereas the control
animals showed evident alterations in the lungs, lymph nodes,
livers, spleens and kidneys (Fig. 1 a–e, Panel b). Haemorrhage,
effusion and edema, inflammatory cell infiltration, and abscess
containing Y. pestis were observed in the lung tissues of the control
animals (Fig. 1 a, Panel B). Disappearance of recognizable
architecture, reduced number of lymphocytes, severe congestion
and edema were observed in the lymph nodes (Fig. 1 b, Panel B).
The liver tissues of the control animals showed hepatocyte
swelling, vacuolar degeneration, dilatation and hyperraemia of
the central vein of hepatic lobules, and slight congestion within
sinus hepaticus (Fig. 1 c, Panel C). The spleen tissues had reduced
amount of white pulp, acinus lienalis, and lymphocytes and
displayed splenic cord edema (Fig. 1 d, Panel B). Acinus renis
analosis, renal capsule effusion, interstitial edema, and vascular
engorgement were observed in the kidney tissues of the control
animals (Fig. 1 e, Panel B). There were no evident changes in the
heart tissues of the control animal (Fig. 1 f, Panel B).
Localization of Y. pestis within infected animal organs
Giemsa staining was used to identify the presence of Y. pestis
(based on size and morphology) in the different organs of the
immunized animals, as well as those of the control animals after
infection with virulent Y. pestis strain 141. No bacteria were
observed within the tissues of lungs, livers, kidneys, lymph nodes,
brains, spleens, and blood from heart of the immunized animals,
whereas bacteria were clearly visible within those of the control
animals (Fig. 2, Panels A–H).
Ultrastructural examination also revealed bacteria in the lymph
nodes, spleens, livers and lungs of the control animals (Fig. 3,
Panels A–D). No bacteria were observed in the corresponding
organs of the immunized animals.
The F1 antigen of Y. pestis was identified by immunohisto-
chemitry staining in the formalin-fixed paraffin-embedded tissues.
Bacteria could be visualized as those expressing the F1 antigen
(brown and yellow stain). Numerous bacteria were observed in the
tissues of the control animals (Fig. 4. Panels A–E) and no bacteria
were found in the naı ¨ve control animal tissues and in tissues of the
immunized animals.
Inspection of basement membranes
The ultrastructure of the GBMs in the immunized and the
control animals after the Y. pestis challenge were observed under
transmission electron microscopy. Histological examination of
renal tissues revealed no signs of immune complex deposition on
the GBMs (Fig. 5, Panels A–D).
Discussion
Currently, evaluation of plague vaccines is often based on
antibody response, cell-mediated immunity and protective effica-
cy. Subunit vaccines in alhydrogel elicit a predominant response to
the F1 and V antigens by procucing IgG1, and total IgG titres
correlate with protection against plague in mice [14]. However,
specific IgG titers to F1 and V antigens do not correlate with
protective efficacy in non-human primates [15,16]. A great deal of
evidence has demonstrated that antibody titers alone do not suffice
in predicting the protective efficacy of plague vaccines. Vaccines
that elicit both humoral and cellular immunity can contribute to
optimal defense against pneumonic plague [17]. However, our
previous study [4] and several reports [18,19,20] have demon-
strated that subunit vaccines in alhydrogel elicit robust humoral
immunity, but their potential in priming effective cellular
immunity has yet to be demonstrated. Under these circumstances,
mortality in response to experimental plague challenges is the most
important data for evaluating the efficacy of plague subunit
vaccines. Although complete protection against subcutaneous
challenge with 6610
6 CFU of virulent Y. pestis strain 141 was
observed in the Chinese-origin rhesus macaques immunized with
SV1, SV2, and EV76 and the control animals succumbed to the
same dose within 3 to 5 days [13], we are unsure whether the
vaccines can effectively protect the immunized animals from any
pathological changes in different organs, whether the control
animals died from specific Y. pestis infection, or whether Chinese-
origin rhesus macaques subcutaneously infected with virulent Y.
pestis has similar histopathologic features as human bubonic plague
or those of other animals.
Cornelius et al. examined the lungs of infected cynomolgus
macaques by aerosol with Y. pestis CO92 for histopathologic
changes associated with infection. The results showed clear
differences between the adjuvant-immunized animals and the
cynomolgus macaques immunized with rLcrV, rV10, or rF1. The
lungs of all the control animals and one rF1-vaccinated macaque
that succumbed to infection had multiple areas of severe
congestion and hemorrhage, whereas other immunized macaques
did not demonstrate any clear gross or histopathological changes
in their lung tissues [5]. To evaluate histopathologically the
protective efficacy of the F1+rV270 subunit vaccine and the EV76
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heart tissues from the immunized and control macaques were
examined under microscopy. The immunized animals did not
display any histopathological lesions in all the examined tissues,
whereas the control animals showed different degrees of patho-
logical alterations in the lungs, lymph nodes, livers, spleens, and
kidneys. In addition, Giemsa staining, ultrastructural examination,
and immunohistochemical staining revealed bacteria in all the
organs of the control animals, whereas no bacteria was observed in
the immunized animals. However, in the present study, the tissues
were only examined at 14 days after the challenge. The possibility
of histopathological lesion and bacterial presence at earlier stages
of infection should not be excluded. In our previous study, post-
mortem analysis of the Y. pestis load in the livers, spleens, lungs,
lymph nodes, and blood from hearts of macaques immunized with
subunit vaccines (SV1 and SV2) and live attenuated vaccine EV76
showed that Y. pestis was eliminated from the immunized animals,
whereas Y. pestis was isolated from the organs of the control
Figure 1. Histopathology of the organs from the immunized animals, the control animals, and the naı ¨ve control animal. Tissue sections
were stained with hematoxylin andeosin forpathologicalexaminationafter infectionwith Y. pestis. (a)Tissue sections from the naı ¨ve controlanimal that
wasneither immunizedwithplaguevaccinesoraluminumhydroxideadjuvantnorinfected withY.pestis.(b) Tissue sectionsfromthecontrolanimal that
only received aluminum hydroxide adjuvant before it was infected by virulent Y. pestis strain 141. (c) Tissue sections from the animals immunized with
SV1 and then infected with virulent Y. pestis strain 141. (d) Tissue sections from the animals immunized with SV2 and then infected with virulent Y. pestis
strain 141. (e) Tissue sections from the animals immunized with EV76 and then infected with virulent Y. pestis strain 141.
doi:10.1371/journal.pone.0019260.g001
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19260Figure 2. Giemsa staining was done to visualize the bacteria in tissues. The bacteria were clearly visible within the tissues from the lungs,
livers, kidneys, lymph nodes, brains, spleens, and blood from heart of the control animals that were only immunized with aluminum hydroxide
adjuvant before they were infected with virulent Y. pestis strain 141. The lungs showed several large clumps of bacteria in the alveolar septum (a,
arrows). Bacteria were also found inside blood vessels in the lungs (b, arrows) and blood from heart (d, arrows). Several large clumps of bacteria were
shown in the hepatic sinus (c, arrows). Medullary cords of the lymph nodes were damaged and occupied by a large number of bacteria (e, arrows).
The spleen show many large clumps of bacteria (f, arrows). Smaller clumps of bacteria are shown within the glomcrulus (g, arrows) and blood vessels
in brain tissue (h, arrows).
doi:10.1371/journal.pone.0019260.g002
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mortem analysis and the current study demonstrat that SV and
EV76 can effectively protect Chinese-origin rhesus macaques from
pathological changes in the examined organs and eliminate Y.
pestis. The control animals died from the lesions of many organs
caused specifically by Y. pestis infection. Although survival rates in
experimental infection are important for evaluating the efficacy of
plague subunit vaccines, lesion severity may have better correla-
tion with survival. Non-specific death is often observed in the
course of experiments, so pathological observation can precisely
provide the most important criterion for evaluating the efficacy of
plague vaccines.
Histopathological examination is useful for evaluating the
efficacy of new plague vaccines and for better understanding of
the pathogenesis of the disease. The current scenario suggests that
bacteria enter the lymphatic system from infected fleabite site,
localize in the regional draining lymph node, and grow to large
numbers, causing formation of ‘‘buboes’’ (swollen lymph nodes).
Without timely effective treatment, Y. pestis spreads from the
lymph nodes to the blood, followed by colonization of internal
organs and secondary bacteremia. Patients usually die from
uncontrolled septicemia, endotoxic shock, and disseminated
intravascular coagulation [3,10]. Although the pathological
characteristics of pneumonic plague have been investigated in
nonhuman primates, such as Indonesian cynomolgus macaques
[11] and African green monkeys [12], the present study is the first
to provide a thorough description of the histopathology of bubonic
plague in Chinese-origin rhesus macaques. Although the chrono-
logical course of infection after Y. pestis inoculation into the skin of
Chinese-origin rhesus macaques was not investigated, the results
Figure 3. Transmission electron micrographs of the organs of the control animals. Transmission electron micrographs of the lymph nodes,
spleen, liver, and lungs of the control animals that were only immunized with aluminum hydroxide adjuvant and then infected with virulent Y. pestis
strain 141. The tissues were fixed in 3.1% glutaraldehyde solution and then postfixed in 1% osmium tetroxide. Afterwards, the tissue samples were
dehydrated with a serial alcohol gradient, and then embedded in Epon812. Ultrathin sections were stained with uranyl acetate and lead citrate and
examined under a Philips Tecnai 10 transmission electron microscope. Ultrastructural examination shows that lymph node tissue structures were
destroyed and a large number of bacteria are found in the interstitium (a). The Splenic pulp shows a large number of bacteria and its structure was
destroyed (b). A large number of bacteria are found around Kupffer’s cells (c). Three Y. pestis were observed in blood vessel of lungs (d).
doi:10.1371/journal.pone.0019260.g003
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macaques results in bubonic, septicemic, and pneumonic plague.
The histopathologic features of plagues closely resemble those of
rodent and human bubonic plague [10]. Control animals develop
a bubonic form of the disease with varying degrees of internal
organ involvement (lungs, lymph nodes, liver, spleens, and
kidneys) except for heart tissues. Giemsa staining revealed that
Y. pestis escape the inoculation site and enter the blood stream,
suggesting that bubonic plague progresses to septicemic plague in
the course of 3–5 days. More importantly, there were clear signs of
infection in the lungs of the control animals, indicating that
subcutaneous injection resulted in secondary pneumonic infection.
Bubonic plague, the most common form of the disease in rodents
and humans, is usually acquired from the bite of an infected flea.
In the present study, the subcutaneously infected Chinese-origin
rhesus macaques developed bubonic plague, followed by pneu-
monic and septicemic plague. Thus, Chinese-origin rhesus
macaques can serve as useful models for studying microbial
pathogenesis, host response, and the efficacy of new medical
countermeasures against plague.
Antigen clearance is normally dependent on the formation of
antigen-antibody complexes and their removal by mononuclear
phagocytes of the reticuloendothelial system. However, occasion-
ally, immune complexes persist and eventually deposit in a range
of tissues and organs. Under such abnormal circumstances,
immune complexes are capable of triggering a wide variety of
inflammatory processes by cell-mediated or complement-mediated
events, causing damage to underlying tissues [21,22]. Several
studies have demonstrated that sequential administration of a
cationic antigen and its corresponding antibodies or the initial
administration of cationic antibodies followed by the specific
antigen leads to formation of subepithelial immune deposits in the
capillary basement membrane of glomeruli. Deposition requires
vascular permeability and occurs mostly at sites of high pressure
and turbulence such as the kidneys. In addition, immune
complexes often deposit around the walls of small blood vessels.
Immune complex deposition occurs mostly in glomerular
capillaries, choroid plexus, and lung alveoli [21,23,24]. Plague
vaccines elicit high level of antibodies specific to the F1 or V
antigen in humans or animals. Repeated vaccination is often
needed to maintain good efficacy, and occasionally vaccinated
humans or animals are still subject to Y. pestis infection. Under
these two circumstances, the formation of immune complex
deposits in the glomerular capillary basement membrane may
cause serious kidney damage. However, whether plague vaccines
cause damage to the renal tissues of the immunized animals after
Y. pestis infection has not been reported. In the present study, the
GBMs of the immunized macaques were examined under electron
microscopy to evaluate the safety of the subunit vaccines. The
results show no signs of immune complex deposition on
glomerular basement membranes. The current study is a follow-
up research to our previous study [13], and does not include a
positive control with respect to immune complex deposition on the
GBMs. Therefore, we suggest that antibodies induced by SV1,
SV2, and EV76 might not result in unintended effects that can
potentially cause toxicity, such as an immune-mediated disease
resulting from the deposition of immune complexes in Chinese-
origin rhesus macaques.
In conclusion, we have demonstrated that plague subunit
vaccines and live attenuated vaccine EV76 can protect rhesus
macaques from any histopathologic lesion in the lungs, livers,
kidneys, lymph nodes,spleensandhearts oftheimmunized animals.
Figure 4. The F1 antigen of Y. pestis was identified by Immunohistochemitry staining. The F1 antigen of Y. pestis was identified by
Immunohistochemitry staining in formalin-fixed paraffin-embedded tissues from the control animals that were only immunized with aluminum
hydroxide adjuvant and then infected with virulent Y. pestis strain 141. The sections were incubated for 12 h with the purified rabbit anti-F1 antigen
of Y. pestis polyclonal antibody at 4uC, and incubated for 10–20 min with the polyperoxidase-anti-rabbit IgG at 37uC. The slides were stained with 3,
39-diaminobenzidine tetrahydrochloride (DAB). Finally, the sections were rinsed, counterstained, dehydrated, cleaned, mounted and examined by
light microscopy. Bacteria were visualized as those expressing F1 antigen (brown and yellow stain). Numerous bacteria were observed in the tissues
of the lymph node (a), spleen (b), liver (c), kidneys (d) or lungs (e). No bacterium was found in the control spleen (f).
doi:10.1371/journal.pone.0019260.g004
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control animals. Giemsa staining, ultrastructural examination, and
immunohistochemical staining revealed bacteria in some organs of
the control animals, whereas no bacteria were observed in the
immunized animals. The results show that the plague vaccines can
effectively protect rhesus macaques from pathological changes and
eliminate Y. pestis from the immunized animals. The control animals
died from multi-organ lesions specifically caused by the Y. pestis
infection. These observations are consistent with the protective
efficacy and antibody responses determined in our previous study
[13]. Thus, histopathological observation, Giemsa staining, ultra-
structural examination, and immunohistochemical staining provide
effective means for evaluating plague vaccines.
Materials and Methods
Vaccines and animals
The subunit vaccine F1+rV270 was prepared as previously
mentioned, which comprise native F1 and rV270 antigens
adsorbed onto 25% (v/v) aluminum hydroxide adjuvant in PBS
buffer [4]. Adsorption of the proteins onto the adjuvant was
checked by subtracting the remaining protein in the supernate
from the total amount of proteins added. The live attenuated
vaccine EV76 was obtained from the Lanzhou Institute of
Biological Products (LIBP), China. Adult male and female
Chinese-origin rhesus macaques were obtained from the Labora-
tory Animal Center, Academy of Military Medical Science, China
[under licensed from the Ministry of Health in General Logistics
Department of Chinese People’s Liberation Army, Permit
No. SCXK-2007-004]. The animals were 3–6 years old and
weighed between 3 and 6 kg. The animal experiments were
conducted in strict compliance with animal welfare regulations,
and the steps taken to ameliorate suffering were in accordance
with the recommendations of the Weatherall Report on the use of
non-human primates in research [25]. All of the animals were
raised in an air-conditioned laboratory with an ambient
temperature of 21–25uC, a relative humidity of 40%–60% and a
12 h light/dark cycle. Each animal was kept in a suspended
Figure 5. Ultrastructure of the glomerular basement membranes of the immunized animals after the Y. pestis challenge. The control
animals infected with Y. pestis were observed under a transmission electron microscope. Transmission electron micrograph of the glomerular
basement membrane (GBM) of the control animal that that were only immunized with aluminum hydroxide adjuvant and then infected with virulent
Y. pestis strain 141 (a), the animal immunized with EV76 (b), the animal immunized with subunit vaccine SV1 (c), and the animal immunized with
subunit vaccine SV2 (d).
doi:10.1371/journal.pone.0019260.g005
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diet of approximately 150 g of standard monkey keeping diet per
day. Fresh fruit was given once daily to each of the animals, and
water was available ad libitum during the entire course of this study.
Animal immunizations
A total of 14 Chinese-origin rhesus macaques were divided into
four groups, three experimental groups and one control group.
Each of the three experimental groups contained four animals (two
male and two female). The alum-immunized control group had
two animals (one male and one female). The animals in each
experimental group were intramuscularly injected in the forelimbs
with one of the following vaccines: SV1 (20 mg of F1 and 10 mgo f
rV270), SV2 (200 mg of F1 and 100 mg of rV270), and EV76 [
one-half of the human dose (8610
8 cells)]. Each animal in the
control group was intramuscularly given 25% aluminum hydrox-
ide adjuvant only. At 21 days after the first immunization, all the
animals were boosted with an identical dose at the same injection
sites.
Animal Infections
The virulent Y. pestis strain 141 was isolated from Marmota
himalayana in the Qinghai Tibet Plateau and has a median lethal
dose (MLD) of 5.6 CFU for BALB/c mice, and 17.8 CFU for
guinea pigs and New Zealand white rabbits by subcutaneous
route. The Y. pestis was cultured in Luria broth at 28uC for 18 h,
quantified by Maxwell turbidimetry, and diluted in sterile
phosphate-buffered saline (PBS). The number of Y. pestis in the
dilution was verified by colony-forming units (CFU) on Y. pestis
selective agar medium. The 14 immunized animals were infected
subcutaneously with 6610
6 CFU on Week 10 after the primary
immunization and closely observed for 14 days. All the animal
experiments were performed in ABSL-3 laboratory.
Histopathology
Tissues collected from dead animals were placed into 10%
neutral buffered formalin, dehydrated through a serial alcohol
gradient (70%, 80%, 90%, 95%, and 100%), cleared with xylene,
infiltrated with wax, and then embedded in paraffin [26]. The
surviving animals at Day 14 after the challenge and one uninfected
animal were humanely killed by intraperitoneal injection of
barbital sodium. As stated above, their tissues were removed and
fixed in 10% neutral buffered formalin for paraffin block
preparation. Tissue sections were stained with hematoxylin and
eosin (HE) for histopathological examination, and the presence of
Y. pestis was detected by Giemsa staining under light microscopy.
Ultra-structural observation
A small section of tissues was removed, fixed for 6 h in 3.1%
glutaraldehyde solution at 4uC and then post-fixed for 2 h in 1%
osmium tetroxide at 4uC. Afterwards, the tissue samples were
dehydrated using a series of alcohol gradient (50%, 70%, 90%,
and 100%), and then embedded in Epon 812. Ultrathin sections
were mounted on 230-mesh copper grids, and then stained with
1% uranyl acetate and lead citrate, and finally examined for
bacteria and immune complex deposition on the glomerular
basement membranes (GBMs) under a Philips Tecnai 10
transmission electron microscope [27].
Immunohistochemistry (IHC)
IHC staining was performed following the user’s manual of the
PV-9000 Kit (ZSGB-Bio) [28]. Briefly, after the paraffin-
embedded tissue sections were deparaffinized and rehydrated,
the sections were subjected to antigen exposure in citrate buffer
solution (0.1 M, pH 6.0) by microwaving at 95uC for 20 min, and
incubated with 3% H2O2 in methanol for 10 min to block
endogenous peroxidase activity. The sections were incubated for
12 h with the purified rabbit anti-F1 antigen of Y. pestis polyclonal
antibody at 4uC, whereas the control spleen tissues were incubated
in PBS. The sections were incubated with Polymer Helper for
20 min at 37uC, and then with polyperoxidase antirabbit IgG
(ZSGB-Bio) for 10–20 min at 37uC. The slides were stained with
3, 39-diaminobenzidine tetrahydrochloride (DAB). Finally, the
sections were rinsed, counterstained, dehydrated, cleaned, mount-
ed, and examined under light microscopy [29].
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